191 related articles for article (PubMed ID: 21908192)
1. Design, synthesis and vasorelaxant evaluation of novel coumarin-pyrimidine hybrids.
Amin KM; Awadalla FM; Eissa AA; Abou-Seri SM; Hassan GS
Bioorg Med Chem; 2011 Oct; 19(20):6087-97. PubMed ID: 21908192
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of novel hybrid chalcone derivatives as vasorelaxant agents.
Dong X; Du L; Pan Z; Liu T; Yang B; Hu Y
Eur J Med Chem; 2010 Sep; 45(9):3986-92. PubMed ID: 20566231
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and vasorelaxant and platelet antiaggregatory activities of coumarin-resveratrol hybrids.
Vilar S; Quezada E; Santana L; Uriarte E; Yánez M; Fraiz N; Alcaide C; Cano E; Orallo F
Bioorg Med Chem Lett; 2006 Jan; 16(2):257-61. PubMed ID: 16275073
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and biological evaluation of prenylated chalcones as vasorelaxant agents.
Dong X; Chen J; Jiang C; Liu T; Hu Y
Arch Pharm (Weinheim); 2009 Jul; 342(7):428-32. PubMed ID: 19544479
[TBL] [Abstract][Full Text] [Related]
5. Analgesic, anti-pyretic and DNA cleavage studies of novel pyrimidine derivatives of coumarin moiety.
Keri RS; Hosamani KM; Shingalapur RV; Hugar MH
Eur J Med Chem; 2010 Jun; 45(6):2597-605. PubMed ID: 20356657
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of 4H-chromene, coumarin, 12H-chromeno[2,3-d]pyrimidine derivatives and some of their antimicrobial and cytotoxicity activities.
Sabry NM; Mohamed HM; Khattab ES; Motlaq SS; El-Agrody AM
Eur J Med Chem; 2011 Feb; 46(2):765-72. PubMed ID: 21216502
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and analgesic activity of novel pyrimidine derivatives of coumarin moiety.
Gupta JK; Sharma PK; Dudhe R; Mondal SC; Chaudhary A; Verma PK
Acta Pol Pharm; 2011; 68(5):785-93. PubMed ID: 21928726
[No Abstract] [Full Text] [Related]
8. Synthesis and evaluation of 2-substituted-6-phenyl-4,5-dihydropyridazin-3(2H)-ones as potent inodilators.
Kumar D; Carron R; La Calle CD; Jindal DP; Bansal R
Acta Pharm; 2008 Dec; 58(4):393-405. PubMed ID: 19103574
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, biological evaluation and structure-activity relationships of new phthalazinedione derivatives with vasorelaxant activity.
Munín J; Quezada E; Cuiñas A; Campos-Toimil M; Uriarte E; Santana L; Viña D
Eur J Med Chem; 2014 Jul; 82():407-17. PubMed ID: 24929291
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and vasorelaxant activity of new coumarin and furocoumarin derivatives.
Campos-Toimil M; Orallo F; Santana L; Uriarte E
Bioorg Med Chem Lett; 2002 Mar; 12(5):783-6. PubMed ID: 11859002
[TBL] [Abstract][Full Text] [Related]
11. Rational design, synthesis and QSAR study of vasorelaxant active 3-pyridinecarbonitriles incorporating 1H-benzimidazol-2-yl function.
Nofal ZM; Srour AM; El-Eraky WI; Saleh DO; Girgis AS
Eur J Med Chem; 2013 May; 63():14-21. PubMed ID: 23454530
[TBL] [Abstract][Full Text] [Related]
12. A novel synthesis of 3-aryl coumarins and evaluation of their antioxidant and lipoxygenase inhibitory activity.
Roussaki M; Kontogiorgis CA; Hadjipavlou-Litina D; Hamilakis S; Detsi A
Bioorg Med Chem Lett; 2010 Jul; 20(13):3889-92. PubMed ID: 20627725
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antibacterial activity of quinolone-based compounds containing a coumarin moiety.
Emami S; Foroumadi A; Faramarzi MA; Samadi N
Arch Pharm (Weinheim); 2008 Jan; 341(1):42-8. PubMed ID: 18072241
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, vasorelaxant activity and 2D-QSAR study of some novel pyridazine derivatives.
George RF; Saleh DO
Eur J Med Chem; 2016 Jan; 108():663-673. PubMed ID: 26735908
[TBL] [Abstract][Full Text] [Related]
15. Chiral pyrrolo[2,3-d]pyrimidine and pyrimido[4,5-b]indole derivatives: structure-activity relationships of potent, highly stereoselective A1-adenosine receptor antagonists.
Müller CE; Geis U; Grahner B; Lanzner W; Eger K
J Med Chem; 1996 Jun; 39(13):2482-91. PubMed ID: 8691445
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and QSAR studies of pyrimido[4,5-d]pyrimidine-2,5-dione derivatives as potential antimicrobial agents.
Sharma P; Rane N; Gurram VK
Bioorg Med Chem Lett; 2004 Aug; 14(16):4185-90. PubMed ID: 15261267
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, antitumor activity and molecular docking study of novel benzofuran-2-yl pyrazole pyrimidine derivatives.
El-Zahar MI; Adb El-Karim SS; Haiba ME; Khedr MA
Acta Pol Pharm; 2011; 68(3):357-73. PubMed ID: 21648190
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and in vivo analgesic and anti-inflammatory activity of some bi heterocyclic coumarin derivatives.
Ghate M; Kusanur RA; Kulkarni MV
Eur J Med Chem; 2005 Sep; 40(9):882-7. PubMed ID: 16140424
[TBL] [Abstract][Full Text] [Related]
19. Benzofuran-morpholinomethyl-pyrazoline hybrids as a new class of vasorelaxant agents: synthesis and quantitative structure-activity relationship study.
Hassan GS; Rahman DE; Abdel Saleh DO; Abdel Jaleel GA
Chem Pharm Bull (Tokyo); 2014; 62(12):1238-51. PubMed ID: 25450632
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, pharmacological evaluation and docking studies of coumarin derivatives.
Sandhya B; Giles D; Mathew V; Basavarajaswamy G; Abraham R
Eur J Med Chem; 2011 Sep; 46(9):4696-701. PubMed ID: 21816516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
